LEQVIO® is the first and only treatment for LDL-C
that is 2 doses a year* administered by a health care provider.†
Another at 3 months
2 doses a year
Single subcutaneous injection via prefilled syringe
LEQVIO should appear clear and colorless to pale yellow. This color variation is normal and has no impact on the overall quality of LEQVIO
*LEQVIO is administered initially, again at 3 months, and then every 6 months.
†Physician, nurse practitioner, physician assistant, or other licensed practitioners.
Dosing regimen may integrate seamlessly
into a patient's health care routine
Not actual size.
LEQVIO transforms the way LDL-C is lowered. In-office administration gives you the confidence that your patients received their dose for 6 months.
Additional dosing information1
LEQVIO is administered into the abdomen, upper arm, or thigh
If planned dose is missed by less than 3 months, administer LEQVIO and maintain dosing according to the patient's original schedule
If a planned dose is missed by more than 3 months, start a new dosing schedule—administer initially, again at 3 months, and then every 6 months
In-office administration of LEQVIO adds minimal burden to your patients' existing medication and care regimen
Reduces LDL-C without adding an additional daily treatment
No specific label requirement for post-injection–related safety monitoring
SEE WHAT YOU NEED TO KNOW
ABOUT LEQVIO DOSING
Get the facts on all aspects of LEQVIO administration, including details
on how to inject LEQVIO, key product information, and finding the right
person in your practice to administer.
THERE'S MORE TO KNOW ABOUT LEQVIO
Explore the LEQVIO mechanism of actionDISCOVER THE MOA
LDL-C, low-density lipoprotein cholesterol.